Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Phase II study of cetuximab in patients with unresectable or metastatic hepatocellular carcinoma

Zhu AX, Blaszkowsky L, Enzinger PC, Bhargava P, Ryan DP, Meyerhardt J, Horgan K, Hale K, Sheehan S, Stuart K. . Phase II study of cetuximab in patients with unresectable or metastatic hepatocellular carcinoma. Gastrointestinal ASCO Symposium. 2005; 197:183.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.